Extracorporeal membrane oxygenation is first-line therapy for acute respiratory distress syndrome

Critical Care Medicine

Volumn 45, Issue 12, 2017, Pages 2070-2073

  Abrams, Darryl ^a   Brodie, Daniel ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Prone positioning; Transport; Ventilator associated lung injury

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ALGORITHM; CLINICAL COMPETENCE; EXTRACORPOREAL OXYGENATION; HUMAN; INTENSIVE CARE; PATIENT TRANSPORT;

ALGORITHMS; CLINICAL COMPETENCE; CRITICAL CARE; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; PATIENT TRANSFER; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85043720964     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002734     Document Type: Note

References (25)

1. Fan E, Gattinoni L, Combes A, et al: Venovenous extracorporeal membrane oxygenation for acute respiratory failure: A clinical review from an international group of experts. Intensive Care Med 2016; 42: 712-724
2. Abrams D, Brodie D: The clinical management of patients on partial/ total extracorporeal support. Curr Opin Crit Care 2016; 22:73-79
3. Terragni PP, Del Sorbo L, Mascia L, et al: Tidal volume lower than 6 ml/kg enhances lung protection: Role of extracorporeal carbon dioxide removal. Anesthesiology 2009; 111:826-835
4. Bein T, Weber-Carstens S, Goldmann A, et al: Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: The prospective randomized Xtravent-study. Intensive Care Med 2013; 39:847-856
5. Grasso S, Stripoli T, Mazzone P, et al: Low respiratory rate plus minimally invasive extracorporeal Co2 removal decreases systemic and pulmonary inflammatory mediators in experimental acute respiratory distress syndrome. Crit Care Med 2014; 42:e451-e460
6. Abrams D, Brodie D: Extracorporeal circulatory approaches to treat acute respiratory distress syndrome. Clin Chest Med 2014; 35:765-779
7. Brower RG, Matthay MA, Morris A, et al; Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
8. Mercat A, Richard JC, Vielle B, et al; Expiratory Pressure (Express) Study Group: Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 2008; 299:646-655
9. Brodie D, Guérin C: Rescue therapy for refractory ARDS should be offered early: No. Intensive Care Med 2015; 41:926-929
10. Wiedemann HP, Wheeler AP, Bernard GR et al: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
11. Papazian L, Forel JM, Gacouin A, et al; ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363:1107-1116
12. Guérin C, Reignier J, Richard JC: Prone positioning in the acute respiratory distress syndrome. N Engl J Med 2013; 369:980-981
13. Bellani G, Laffey JG, Pham T, et al; LUNG SAFE Investigators; ESICM Trials Group: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315:788-800
14. Needham DM, Yang T, Dinglas VD, et al: Timing of low tidal volume ventilation and intensive care unit mortality in acute respiratory distress syndrome. A prospective cohort study. Am J Respir Crit Care Med 2015; 191:177-185
15. Wallace DJ, Angus DC, Seymour CW, et al: Geographic access to high capability severe acute respiratory failure centers in the United States. PLoS One 2014; 9:e94057
16. Peek GJ, Mugford M, Tiruvoipati R, et al; CESAR trial collaboration: Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 2009; 374:1351-1363
17. Biscotti M, Agerstrand C, Abrams D, et al: One hundred transports on extracorporeal support to an extracorporeal membrane oxygenation center. Ann Thorac Surg 2015; 100:34-39; discussion 39-40
18. Salina M, Biscotti M, Agerstrand C et al: Management of surge in extracorporeal membrane oxygenation transport. Ann Thorac Surg 2017, in press
19. Karagiannidis C, Brodie D, Strassmann S, et al: Extracorporeal membrane oxygenation: Evolving epidemiology and mortality. Intensive Care Med 2016; 42:889-896
20. Marhong JD, Munshi L, Detsky M, et al: Mechanical ventilation during extracorporeal life support (ECLS): A systematic review. Intensive Care Med 2015; 41:994-1003
21. Barbaro RP, Odetola FO, Kidwell KM, et al: Association of hospitallevel volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med 2015; 191:894-901
22. Combes A, Brodie D, Bartlett R, et al; International ECMO Network (ECMONet): Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 2014; 190:488-496
23. Assistance Publique - Hôpitaux de Paris: Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome (EOLIA). In: ClinicalTrials.gov. Bethesda, MD, National Library of Medicine (US), 2000. Available at: Http://clinicaltrials.gov/ct2/ show/NCT01470703. NLM Identifier: NCT01470703. Accessed July 1, 2017
24. Belfast Health and Sociual Care Trust: Protective Ventilation With Veno-venous Lung Assist in Respiratory Failure (REST). In: Clinical-Trials.gov. Bethesda, MD, National Library of Medicine (US), 2000. Available at: Http://clinicaltrials.gov/ct2/show/NCT02654327. NLM Identifier: NCT02654327. Accessed July 11, 2017
25. European Society of Intensive Care Medicine: Strategy of Ultraprotective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to Severe ARDS (SUPERNOVA). In: ClinicalTrials. gov. Bethesda, MD, National Library of Medicine (US), 2014. Available at http://clinicaltrials.gov/ct2/show/NCT02282657. NLM Identifier: NCT02282657. Accessed July 27, 2017